Board Meeting24 Jul 2026, 10:10 pm
Gland Pharma Board Meeting on Aug 10 to Approve Q1 FY27 Results
AI Summary
Gland Pharma Limited has announced that its Board of Directors will convene on August 10, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. Additionally, the company has confirmed the reopening of its trading window on August 13, 2026, following a closure for insider trading compliance. An investor and analyst call is scheduled for the same day as the board meeting.
Key Highlights
- Board meeting scheduled for August 10, 2026.
- To approve Unaudited Standalone and Consolidated Financial Results.
- Results for the quarter ended June 30, 2026, will be considered.
- Trading window reopens on August 13, 2026.
- Investor/Analyst call scheduled for August 10, 2026.
Price Impact
More from GLAND
More in Board Meeting